MOUNTAIN VIEW, Calif., April 26 /PRNewswire-FirstCall/ -- Pharsight Corporation , a leading provider of software and strategic services for optimizing clinical drug development, today announced that it will release financial results for the fiscal fourth quarter and full year 2007, which ended March 31, 2007, after the market closes on Thursday, May 10, 2007. The Company will host a conference call and webcast on Friday, May 11, 2007 at 10:00 a.m. Pacific Time to discuss the Company’s fiscal fourth quarter and full year results, and current corporate developments. The dial-in number for the conference call is 800-218-8862 for domestic participants and 303-262-2130 for international participants.
A taped replay of the conference call will also be available beginning approximately one hour after the call’s conclusion and will remain available for seven days. This replay can be accessed by dialing 800-405-2236 for domestic callers and 303-590-3000 for international callers, using passcode 11088662#. To access the live webcast of the call, go to Pharsight’s website at www.pharsight.com. An archived webcast will also be available at www.pharsight.com.
About Pharsight Corporation
Pharsight Corporation develops and markets integrated products and services that enable pharmaceutical and biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products. The company’s goal is to help customers reduce the time, cost and risk of drug development, as well as optimize the post-approval marketing and use of pharmaceutical products.
Pharsight’s approach enhances the fundamental element of drug development success: strong decision-making. By adopting the Pharsight approach, customers acquire a new decision-making process with the potential to systematically improve every level and phase of their business and scientific processes. Pharsight is headquartered in Mountain View, California. Information about Pharsight is available at http://www.pharsight.com.
Pharsight Corporation
CONTACT: investors, Jennifer Beugelmans, +1-646-201-5447, or Doug Sherk,+1-415-896-6820, or media, Jennifer Saunders, +1-646-201-5431, both of EVCGroup, for Pharsight Corporation
Web site: http://www.pharsight.com//
